trial · primary record
Nadofaragene Firadenovec
Muscle Invasive Bladder Urothelial Carcinoma
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 33 |
| Primary completion | 2027-02-01 |
| Primary endpoint | Pathological complete response (pCR) on radical cystectomy (RC) specimen |
| Registry ID | NCT07332351 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:03.921Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07332351
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.